Dynamic changes in dopaminergic neurotransmission induced by a low concentration of bisphenol-A in neurones and astrocytes

Journal of Neuroendocrinology

Volumn 18, Issue 6, 2006, Pages 434-444

  Miyatake, M ^a   Miyagawa, K ^a   Mizuo, K ^a   Narita, M ^a   Suzuki, T ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

17 oestradiol; Astrocyte; Bisphenol A; Dopamine; Drug abuse; Neurone

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CALCIUM; CASPASE 3; DOPAMINE; ENDOCRINE DISRUPTOR; ESTRADIOL; FLUTAMIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; MIFEPRISTONE; MORPHINE; TAMOXIFEN;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL COMMUNICATION; CELL CULTURE; CELL DEATH; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; ENZYME ACTIVATION; FEMALE; GLIA CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MESENCEPHALON; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; MOUSE STRAIN; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; STELLATE CELL;

ANALGESICS, OPIOID; ANIMALS; ASTROCYTES; CALCIUM; CELL COMMUNICATION; CELL DEATH; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; ESTROGENS, NON-STEROIDAL; FEMALE; MALE; MICE; MICE, INBRED ICR; MORPHINE; NEURONS; PHENOLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REWARD; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION;

EID: 33646347627     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2006.01434.x     Document Type: Article

References (37)

1. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: An estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 1993; 132: 2279-2286.
2. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 1995; 103: 608-612.
3. Self DW. Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system. Neuropharmacology 2004; 47 (Suppl. 1): 242-255.
4. Ikemoto S, Wise RA. Mapping of chemical trigger zones for reward. Neuropharmacology 2004; 47: 190-201.
5. 1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neuroscience 2003; 117: 639-644.
6. Mizuo K, Narita M, Miyagawa K, Narita M, Okuno E, Suzuki T. Prenatal and neonatal exposure to bisphenol-A affects the morphine-induced rewarding effect and hyperlocomotion in mice. Neurosci Lett 2004; 356: 95-98.
7. 3 receptor. Neurosci Lett 2004; 358: 13-16.
8. 3 receptor in the morphine-induced rewarding effect and hyperlocomotion. J Neurosci 2003; 23: 1006-1012.
9. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function. Brain Res Rev 1999; 30: 77-105.
10. Little AR, O'Callagha JP. Astrogliosis in the adult and developing CNS. is there a role for proinflammatory cytokines? Neurotoxicology 2001; 22: 607-618.
11. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001; 2: 119-128.
12. Hyman SE, Malenka RC. Addiction and the brain. the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001; 2: 695-703.
13. Narita M, Miyatake M, Shibasaki M, Tsuda M, Koizumi S, Narita M, Yajima Y, Inoue K, Suzuki T. Long-lasting change in brain dynamics induced by methamphetamine. Enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization. J Neurochem 2005; 93: 1383-1392.
14. Cyr M, Calon F, Morissette M, Di Paolo T. Estrogenic modulation of brain activity. implications for schizophrenia and Parkinson's disease. J Psychiatry Neurosci 2002; 27: 12-27.
15. McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocr Rev 1999; 20: 279-307.
16. Miyatake M, Narita M, Shibasaki M, Namakukra A, Suzuki T. Eur J Neurosci 2005; 22: 1476-1488.
17. Suzuki T. Conditioned place preference in mice. Meth Find Exp Clin Pharmacol 1996; 18 (Suppl. A): 75-83.
18. Fellin T, Carmignoto G. Neurone-to-astrocyte signalling in the brain represents a distinct multifunctional unit. J Physiol 2004; 559: 3-15.
19. Haydon PG. Glia: Listening and talking to the synapse. Nat Rev Neurosci 2001; 2: 185-193.
20. Inoue K, Kato K, Yoshimura Y, Makino T, Nakazawa H. Determination of bisphenol A in human serum by high-performance liquid chromatography with multi-electrode electrochemical detection. J Chromatogr B 2000; 749: 17-23.
21. 1 receptors. J Neurochem 1997; 69: 639-644.
22. 1 dopamine receptors in the rat brain. J Neurochem 2003; 85: 378-386.
23. 2 receptor in PC-12 cells and regulation of membrane conductances by dopamine. Am J Physiol 1997; 273: C1143 -C1150.
24. 2 receptor in transfected NG108-15 cells. J Neurochem 2002; 82: 316-328.
25. 3 receptor coexistence. Brain Res Rev 1998; 26: 236-242.
26. Surmeier DJ, Eberwine J, Wilson CJ, Cao Y, Stefani A, Kitai ST. Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc Natl Acad Sci USA 1992; 89: 10178-10182.
27. 3 receptors by prenatal and neonatal exposure to an endocrine disruptor bisphenol-A in mice. Addict Biol 2004; 9: 19-25.
28. Narita M, Funada M, Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 2001; 89: 1-15.
29. McBride WJ, Murphy JM, Ikemoto S. Localization of brain reinforcement mechanisms: Intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 1999; 101: 129-152.
30. vom Saal FS, Cooke PS, Buchanan DL, Palanza P, Thayer KA, Nagel SC, Parmigiani S, Welshons WV. A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol Ind Health 1998; 14: 239-260.
31. Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 1997; 105: 70-76.
32. 2 a functional variant of estrogen receptor β expressed in normal rat tissues. Endocrinology 1998; 139: 1082 -1092.
33. Quesada I, Fuentes E, Viso-Leon MC, Soria B, Ripoll C, Nadal A. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17β-estradiol rapidly activate transcription factor CREB. FASEB J 2002; 16: 1671-1673.
34. 2+]i oscillations in mouse oocytes. Biochem Biophys Res Commun 2005; 326: 166-173.
35. Sato K, Matsuki N, Ohno Y, Nakazawa K. Estrogens inhibit 1-glutamate uptake activity of astrocytes via membrane estrogen receptor alpha. J Neurochem 2003; 86: 1498-1505.
36. Chaban VV, Lakhter AJ, Micevych P. A membrane estrogen receptor mediates intracellular calcium release in astrocytes. Endocrinology 2004; 145: 3788-3795.
37. Hosli E, Jurasin K, Ruhl W, Luthy R, Hosli L. Colocalization of androgen, estrogen and cholinergic receptors on cultured astrocytes of rat central nervous system. Int J Dev Neurosci 2001; 19: 11-19.